Author: Vitaliy Dadalyan

AEMD: Oncology EFS Open For Enrollment

AEMD: Oncology EFS Open For EnrollmentBy M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Aethlon Medical Inc. (NASDAQ:AEMD), a medical technology company engaged in developing products to diagnose and treat diseases in oncology and viral diseases that are life and organ threatening and not addressed with already approved treatments, reported 2Q FY 2021 results last night and provided a business update. The company’s lead